Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Geron Corporation    GERN

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/19/2017 06/20/2017 06/21/2017 06/22/2017 06/23/2017 Date
2.7(c) 2.76(c) 2.86(c) 2.94(c) 2.94(c) Last
859 537 1 827 534 1 246 599 1 370 917 1 587 807 Volume
+2.27% +2.22% +3.62% +2.80% 0.00% Change
More quotes
Financials ($)
Sales 2017 16,4 M
EBIT 2017 -19,9 M
Net income 2017 -33,9 M
Debt 2017 -
Yield 2017 -
Sales 2018 41,6 M
EBIT 2018 0,14 M
Net income 2018 2,97 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018 294,00
Capi. / Sales2017 28,6x
Capi. / Sales2018 11,2x
Capitalization 468 M
More Financials
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park,... 
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on GERON CORPORATION
06/23 GERON CORPORATION : Today's Research Reports on Stocks to Watch: Geron Corporati..
05/12 Geron Co. Shares Sold by NJ State Employees Deferred Compensation Plan
05/11 GERON CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
05/10 GERON : reports 1Q loss
05/09 GERON CORP : Results of Operations and Financial Condition, Financial Statements..
05/09 GERON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
05/09 Geron Corporation Reports First Quarter 2017 Financial Results and Recent Eve..
05/01 GERON : Faruqi & Faruqi, LLP Announces a Proposed Class Action Settlement Involv..
04/29 Metropolitan Life Insurance Co. NY Has $233,000 Stake in Geron Co.
04/25 Geron 2017 Annual Meeting of Stockholders to be Held on May 9
More news
Sector news : Bio Therapeutic Drugs
06/23DJOne of the Last Untapped Blockbuster Diseases? Drug Companies Race to Find a ..
06/20 Novartis eye drug works with fewer injections than rival
06/15DJACTELION : J&J Maps Research Plans for Actelion -- WSJ
06/14DJACTELION : Correction to J&J Actelion Story
06/14DJACTELION : J&J Plans to Add Drug Discovery and Early Research to Actelion Unit
More sector news : Bio Therapeutic Drugs
Latest Tweets
02:47aGeron Corporation $GERN Earns Daily News Impact Score of 0.28  
06/23#VolumeRadar $GERN GERON #TradeIdeas via ?  
06/21We have selected 5 must-buy stocks within the biotech sector. $REGN $CBM $GER..
1
06/15Geron Corporation upgraded by Zacks Investment Research to buy. $3.00 PT.  
06/14Geron Corporation downgraded by Zacks Investment Research to hold.  
More tweets
Qtime:20
News from SeekingAlpha
05/12 After Hours Gainers / Losers
05/12 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
05/09 Geron EPS in-line, beats on revenue
05/09 No One Wants To Hear It, But Geron Has A Stake In Spinal Cord Injury Again
05/08 Notable earnings after Tuesday?s close
Advertisement
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Technical analysis trends GERON CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 4,17 $
Spread / Average Target 42%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John A. Scarlett President, Chief Executive Officer & Director
Ho Young Huh Chairman
Olivia K. Bloom Chief Financial Officer, Treasurer & Executive VP
Karin Eastham Independent Director
Robert Jay Spiegel Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GERON CORPORATION42.03%468
AMGEN17.98%126 856
CELGENE CORPORATION16.03%104 873
GILEAD SCIENCES-1.52%92 150
REGENERON PHARMACEUTIC..43.43%54 987
VERTEX PHARMACEUTICALS83.97%33 251
More Results